Masaki Hideki, Miki Takami
Geriatric Medicine, Postgraduate School of Medicine, Osaka City University Medical School.
Clin Calcium. 2006 Jan;16(1):137-44.
Strontium ranelate, which has dual effects of decreasing bone resorption and increasing bone formation, is a new orally active drug to treat osteoporosis. Although the clinical values are scientifically proved and the governments admit as one of the treatment for osteoporosis in many countries, the clinical trial is still undergoing in Japan.
雷奈酸锶具有降低骨吸收和增加骨形成的双重作用，是一种新型口服活性抗骨质疏松药物。尽管其临床价值已得到科学验证，且在许多国家政府已批准其作为骨质疏松症的治疗药物之一，但在日本仍在进行临床试验。
